Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis

• Rafael Diaz de la Guardia,
• Belen Lopez-Millan,
• Heleia Roca-Ho,
• Clara Bueno,
• Francisco Gutiérrez-Agüera,
• Jose Luis Fuster,
• Eduardo Anguita,
• Samanta Romina Zanetti,
• Susana Vives,
• Josep Nomdedeu,
• Robert Sackstein,
• Jessie Lavoie,
• Elena Gónzalez-Rey,
• Mario Delgado,
• Michael Rosu-Myles,
• Pablo Menendez

Affiliations

Rafael Diaz de la Guardia

Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain

Belen Lopez-Millan

Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain

Heleia Roca-Ho

Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain

Clara Bueno

Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain

Francisco Gutiérrez-Agüera

Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain

Jose Luis Fuster

Sección de Oncohematología Pediátrica, Hospital Virgen de Arrixaca, Murcia, Spain

Eduardo Anguita

Servicio de Hematología, Hospital Clínico San Carlos, IdISSC, Medicina UCM, Madrid, Spain

Samanta Romina Zanetti

Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain

Susana Vives

Hematology Department, ICO-Hospital Germans Trias i Pujol and Josep Carreras Leukemia Research Institute, Barcelona, Spain

Josep Nomdedeu

Servicio de Hematología, Hospital de la Santa Creu i Sant Pau and Josep Carreras Leukemia Research Institute, Barcelona, Spain

Robert Sackstein

Department of Medicine and Program of Excellence in Glycosciences, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

Jessie Lavoie

Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, ON, Canada

Elena Gónzalez-Rey

Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain

Mario Delgado

Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain

Michael Rosu-Myles

Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, ON, Canada

Pablo Menendez

Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Spain;Instituciò Catalana de Reserca i EstudisAvançats (ICREA), Barcelona, Spain;Centro de Investigación Biomédica en Red de Cancer (CIBER-ONC), Barcelona, Spain